Bagels & Biotech
May 19, 2026 | 8:30 - 10:00 AM
In-Person ONLY
The Keck Center
500 Fifth Street, NW, Washington, DC 20001
Join the National Academy of Medicine and science, technology, and policy professionals from the Washington, D.C., region for breakfast and conversation as we explore emerging neurotechnologies with a focus on how advances in neural sensing, modulation, and adaptive brain–computer systems are reshaping possibilities for treating neurological and psychiatric conditions.
As tools for decoding, stimulating, and potentially optimizing brain function move from research settings toward clinical and commercial deployment, they raise complex questions around safety, personal agency, data governance, equity, regulatory oversight, and responsible integration into health systems. The event will foster cross-sector dialogue on how innovation in neurotechnology can proceed in ways that are scientifically rigorous, ethically grounded, and socially responsive.
About Bagels & Biotech
Advancements in biomedical and biotechnology research are occurring rapidly, raising complex questions about ethics, accountability, and responsible decision-making and highlighting the need for forums that connect emerging science with its broader societal, medical, and governance implications to promote thoughtful innovation. The quarterly Bagels & Biotech series at the National Academies brings together policy professionals, researchers, ethicists, industry leaders, representatives from patient, community, and civil society organizations, and others in the Washington DC region for in-depth group discussion of an emerging technology or biomedical policy issue and cross-sector dialogue on responsible innovation.